Cite

HARVARD Citation

    Rezaei, G. et al. (2017). Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer. Nanomedicine. pp. 597-613. [Online]. 
  
Back to record